Earnings Feed
Start Free
Benitec Biopharma Inc.·4

Jun 30, 4:20 PM ET

BUCHI J KEVIN 4

Research Summary

AI-generated summary

Updated

Benitec Biopharma Director Kevin J. Buchi Gifts 51,813 Shares

What Happened
Kevin J. Buchi, a director of Benitec Biopharma Inc. (BNTC), disposed of 51,813 shares on 2026-06-29 as a gift (transaction code G). The shares were transferred at $0.00 per share (gift), resulting in no cash proceeds reported on the Form 4.

Key Details

  • Transaction date: 2026-06-29; filing date: 2026-06-30 (Form 4) — appears timely under Form 4 reporting rules.
  • Transaction type/code: Gift (G). Reported price: $0.00 per share.
  • Shares transferred: 51,813. Total cash proceeds: $0 (gift).
  • Shares owned after the transaction: Not specified in the material provided.
  • Footnote: The reporting person transferred the shares to a donor-advised fund sponsored by a Section 501(c)(3) charitable organization.
  • No indication of option exercise, sale for cash, or 10% ownership change in the provided filing.

Context
Gifts to donor-advised funds are charitable transfers and are not the same as market sales; they do not necessarily signal the insider’s view on the company’s prospects. Donor-advised funds allow the donor to recommend grants to charities later, but the filing simply records the transfer of beneficial ownership.